Skip to main content
OpenTrials
Completed

NCT Number: NCT02494180

A Non-inferiority Trial on Pain Relief During Oocyte Retrieval

The objective of the trial is to compare fentanyl and midazolam vs diazepam and pethidine in terms of the pain levels and post-operative side effects of TUGOR

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–40 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

About this study

In-vitro fertilization / embryo transfer (IVF / ET) is a well-established method to treat various causes of infertility. It involves multiple follicular development, retrieval of oocytes and embryo transfer after fertilization. Egg retrieval at the majority of IVF units is performed through the transvaginal route under ultrasound guidance (TUGOR) [1]. During TUGOR, the needle has to pass through the mucosa in the vaginal vault in order to puncture the follicles in the ovary. The procedures are generally short, lasting about 20-30 minutes but are still painful without anaesthesia or analgesia.

Intravenous sedation with or without local anaesthesia is the most widely used method. Conscious sedation is a safe and cost-effective method of providing analgesia and anesthesia for TUGOR. [2] It is easy to administer in cooperative and motivated patients. It has a relatively low risk for adverse effects on oocyte and embryo quality and pregnancy rates. [3] Paracervical block (PCB) in conjunction with conscious sedation during TUGOR was shown to significantly reduce the pain during TUGOR when compared to PCB alone [4].

A Cochrane review on various methods of sedation and analgesia for pain relief during TUGOR has shown no single method or delivery system appeared superior for pregnancy rates and pain relief. [5] Most of the methods seemed to work well and the effect was usually enhanced by addition of another method such as pain relief with paracervical block. [6]

The investigators' reproductive centre has recently aligned with the Assisted Reproduction Centre of the University of Hong Kong (HKU). The investigators are using 0.1mg fentanyl and 5mg midazolam intravenously for pain relief in TUGOR at Kwong Wah Hospital (KWH) whereas 5mg diazepam and 25mg pethidine intravenously are being used in HKU. The investigators would like to compare fentanyl and midazolam vs diazepam and pethidine in terms of pain levels and post-operative side effects of TUGOR in this prospective non-inferiority randomized double-blinded trial. The investigators postulate there are no differences in the pain levels between two groups but the postoperative side effects may be different.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • presence of both ovaries;
  • body mass index less than 30
  • written informed consent and
  • Chinese

Exclusion criteria

  • IVF cycle converted from ovulation induction or intrauterine insemination cycles;
  • patient requests general anaesthesia for TUGOR;
  • history of drug sensitivity to lignocaine/fentanyl/midazolam/diazepam/pethidine;
  • less than 3 dominant follicles present;
  • dominant follicles present in one ovary only and
  • TUGOR performed on one side only.

Treatment and study plan

Fentanyl

Drug

arm A receiving iv fentanyl

Pethidine

Drug

arm B receiving iv pethidine

Diazepam

Drug

arm B receiving iv diazepam

Other names: valium

midazolam

Drug

arm A receiving iv midazolam

Other names: dormicum

Primary outcomes

  1. Pain Level During Oocyte Retrieval

    Time frame: will be assessed within 4 hours of oocyte retrieval

    The pain level will be scored using visual analogue scale 0-10, 0 = no pain, 10 =most painful

  2. Pain Level After Oocyte Retrieval

    Time frame: will be assessed within 4 hours of oocyte retrieval

    The pain level will be scored using visual analogue scale 0-10, 0 = no pain, 10 =most painful

Secondary outcomes

  1. Percentage of Participants With Side Effects by Type

    Time frame: will be assessed within 4 hours of oocyte retrieval

    side effects will be scored by yes or no

  2. Patient's Satisfaction on Oocyte Retrieval

    Time frame: will be assessed within 4 hours of oocyte retrieval

    satisfaction will be scored from 0-3 (0=excellent, 1=satisfactory, 2=fair, 3=unsatisfactory)

  3. Clinical Pregnancy Rate

    Time frame: will be assessed within ten weeks of oocyte retrieval

    presence of intrauterine sac in ultrasound after a positive pregnancy test

  4. Ongoing Pregnancy Rate

    Time frame: will be assessed within ten weeks of oocyte retrieval

    positive fetal heart pulsation seen in ultrasound at eight weeks of gestation

  5. Patient's Satisfaction on Pain Relief

    Time frame: within 4 hours after retrieval

    satisfaction on pain relief will be scored at 0-10 (10 being most satisfied)

  6. Sedation Level

    Time frame: immediately after retrieval

    S = sleeping, easily aroused; 1 = awake and alert; 2 = occasionally drowsy, easy to arouse; 3 = frequently drowsy, arousable, drifts off to sleep during conversation; 4 = somnolent, minimal or no response to stimuli

Sponsors and collaborators

Lead sponsor

Kwong Wah Hospital

Other

Collaborators

  • Queen Mary Hospital, Hong Kong
  • The University of Hong Kong

Registry information

Official study title

A Prospective, Non-inferiority Randomized Double-blinded Trial Comparing Fentanyl and Midazolam vs Diazepam and Pethidine for Pain Relief During Oocyte Retrieval

Important dates

Study start
2016
Primary completion
2018
Study completion
2018
First posted
Jul 10, 2015
Registry last updated
Mar 5, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.